Send Inquiry

Request To Call Back

Rozel 60

Name: Rozel 60
Brand: Ezan Pharmaceuticals
Price: 7000 INR
Availability: InStock

Price 7000 INR/ Unit

Get a Price/Quote

MOQ : 2 Packs

Rozel 60 Specification

Packaging Type
Pre-filled syringe

Life Span
36 months (unopened)

Origin of Medicine
Imported

Brand Name
Denosumab

Dosage Form
Injection

Indication
Postmenopausal osteoporosis, bone loss due to hormone ablation in cancer

Pacakaging (Quantity Per Box)
1 pre-filled syringe

Salt Composition
Denosumab

Drug Type
Other

Ingredients
Denosumab 60 mg/ml

Physical Form
Other

Function
Other

Recommended For
Osteoporosis and bone loss treatment

Dosage
As directed by physician

Dosage Guidelines
Administered via subcutaneous injection every 6 months or as prescribed

Suitable For
Adults, Suitable For All

Quantity
60 ml

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Contraindications
Hypocalcemia, pregnancy, hypersensitivity to denosumab

Special Precautions
Monitor serum calcium levels before each dose and during therapy

Appearance
Clear, colorless to pale yellow solution

Caution
For single use only

Marketing Authorization Holder
As per box details

Prescription Requirement
Prescription Only

ATC Code
M05BX04

Expiry Date
As mentioned on the packaging

Strength/Concentration
60 mg/ml

Regulatory Status
Rx only

Administration Route
Subcutaneous

Common Side Effects
Musculoskeletal pain, skin infection, hypocalcemia

Rozel 60 Trade Information

Minimum Order Quantity
2 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
1 Days

Main Domestic Market
All India

About Rozel 60

Product Name: Rozel 60 mg Injection
Composition: Denosumab Solution
Form: Sterile solution for injection
Type: Prescription-only
Packaging: Vial
Manufacturer: Intas Pharmaceuticals Ltd
Use: Indicated for osteoporosis and bone loss management
Shelf Life: 3 years

Introducing the new release of Denosumab Solution For Injection 60 ml-your unmatchable choice for osteoporosis and bone loss treatment. Decorated with a virtuosic formulation, this pre-filled syringe contains 60 mg/ml of Denosumab in a clear, colorless to pale yellow liquid. Its reduced frequency of administration ensures ease, delivered subcutaneously every six months as prescribed. Get It Now and experience distinguished efficacy! Please note: Prescription required, and special monitoring is essential. Store refrigerated. Single-use only. For adults with osteoporosis or cancer-related bone loss.

Primary Application & Competitive Advantages

Denosumab Solution For Injection 60 ml is administered subcutaneously, targeting the site where bone loss or osteoporosis occurs. Apart from postmenopausal osteoporosis, it is recommended for bone loss due to hormone ablation in cancer. Its primary competitive advantages include a convenient dosing schedule-administered just twice a year-and a pre-filled syringe for safe, single-use application. The efficacy and innovative RANKL inhibition mechanism set this product apart in osteoporosis management.

Supply, Delivery & Market Coverage

Supplied via reputable channels, Denosumab Solution For Injection 60 ml can be offered FOB at major ports, covering India's main domestic markets. Delivered in secure, refrigerated packaging to maintain quality and efficacy, this product ensures quick and reliable availability for healthcare providers. Sample availability may be discussed to facilitate institutional supply, ensuring a reliable source for clinics and hospitals seeking premium bone loss therapies.

FAQ's of Denosumab Solution For Injection 60 ml:

Q: How should Denosumab Solution For Injection 60 ml be administered?

A: Denosumab Solution should be administered by subcutaneous injection every six months, following physician guidance. It is available in a pre-filled syringe for single use only.

Q: What are the main benefits of using this Denosumab injection?

A: Denosumab offers reduced frequency dosing, unmatchable effectiveness in inhibiting bone resorption, and is virtuoso in treating osteoporosis and bone loss related to hormonal treatments in cancer.

Q: When should serum calcium levels be monitored during treatment?

A: Serum calcium should be monitored before administering each dose and periodically during therapy to ensure patient safety and optimal results.

Q: Where should the solution be stored to maintain its efficacy?

A: The pre-filled syringe must be stored in a refrigerator at 2C to 8C. Do not freeze. Proper storage preserves the solution's potency for up to 36 months unopened.

Q: What is the process if a patient is hypersensitive to Denosumab?

A: Usage is contraindicated for patients with hypersensitivity to Denosumab. Such individuals should discuss alternative treatments with their healthcare provider immediately.

Tell us about your requirement